38,652 Shares in Sotera Health Company $SHC Acquired by Entropy Technologies LP

Entropy Technologies LP acquired a new position in Sotera Health Company (NASDAQ:SHC) in the first quarter, HoldingsChannel reports. The institutional investor acquired 38,652 shares of the company’s stock, valued at approximately $554,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in SHC. IFP Advisors Inc lifted its holdings in Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares in the last quarter. Rothschild Investment LLC purchased a new stake in Sotera Health during the 4th quarter valued at approximately $27,000. Root Financial Partners LLC grew its holdings in Sotera Health by 217.5% during the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after buying an additional 1,455 shares in the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in shares of Sotera Health during the fourth quarter valued at approximately $40,000. Finally, Allworth Financial LP raised its position in shares of Sotera Health by 922.0% during the fourth quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock valued at $53,000 after buying an additional 2,729 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Down 1.3%

Shares of SHC opened at $17.53 on Thursday. The stock has a market capitalization of $5.00 billion, a price-to-earnings ratio of 42.76 and a beta of 1.76. Sotera Health Company has a 1 year low of $11.00 and a 1 year high of $19.85. The business’s 50 day simple moving average is $16.78 and its 200-day simple moving average is $16.36. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. During the same period in the prior year, the company earned $0.14 EPS. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, equities analysts expect that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SHC has been the subject of a number of research reports. Piper Sandler restated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. UBS Group set a $19.00 price target on shares of Sotera Health in a research note on Wednesday, June 24th. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Finally, Barclays raised their price objective on Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $20.25.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 15.36% of the stock is currently owned by insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.